PIEZOELECTRIC CRYSTALS AND THEIR APPLICATION TO ULTRASONICS.

Por MASON W P.
Publicado em C1950

PHYSICAL ACCOUSTICS;PRINCIPLESAND METHODS,V1 PT A.

Por MASON W P.
Publicado em S1964

ELECTROMECHANICAL TRANSDUCERS AND WAVES FILTERS.

Por MASON W P.
Publicado em C1948

PHYSICAL ACOUSTICS AND THE PROPERTIES OF SOLIDS.

Por MASON W P.
Publicado em C1958

Spontaneous neurological improvement in anti-Hu associated encephalomyelitis.

Por Byrne, T, Mason, W P, Posner, J B, Dalmau, J
Publicado em 1997

Human papillomavirus detection by hybrid capture and its possible clinical use.

Por Farthing, A, Masterson, P, Mason, W P, Vousden, K H
Publicado em 1994

The views of patients with brain cancer about palliative care: a qualitative study

Por Vierhout, M., Daniels, M., Mazzotta, P., Vlahos, J., Mason, W.P., Bernstein, M.
Publicado no Curr Oncol (2017)

FINAL REPORT OF THE COMMITTEE ON STANDARD METHODS FOR THE EXAMINATION OF AIR

Por Winslow, C.-E. A., Crowder, T. R., Mason, W. P., Phelps, E. B., Whipple, G. C.
Publicado em 1917

Hypothalamic hypopituitarism in a patient with a basal encephalocoele--treatment with luteinizing hormone-releasing hormone.

Por Morris, D. V., Mason, W. P., Wilson-Holt, N., Adams, J., Keene, M., Tanner, J., Jacobs, H. S.
Publicado em 1984

Canadian recommendations for the treatment of glioblastoma multiforme

Por Mason, W.P., Maestro, R. Del, Eisenstat, D., Forsyth, P., Fulton, D., Laperrière, N., Macdonald, D., Perry, J., Thiessen, B.
Publicado em 2007

Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions.

Por Hird, V., Stewart, J. S., Snook, D., Dhokia, B., Coulter, C., Lambert, H. E., Mason, W. P., Soutter, W. P., Epenetos, A. A.
Publicado em 1990

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme

Por Easaw, J.C., Mason, W.P., Perry, J., Laperrière, N., Eisenstat, D.D., Del Maestro, R., Bélanger, K., Fulton, D., Macdonald, D.
Publicado em 2011

O10.09 REDUCTION IN NEUTROPHIL-LYMPHOCYTE RATIO DURING INITIAL CONCURRENT CHEMORADIOTHERAPY IS PROGNOSTIC FOR SURVIVAL OF GLIOBLASTOMA PATIENTS

Por Mason, M.T., McNamara, M.G., Tieu, M.T., Lwin, Z., Millar, B.A., Menard, C., Laperriere, N., Milosevic, M., Mason, W.P., Chung, C.
Publicado em 2014